Home Archive
Archive
2024 Volume 45 Issue 1  Published: 2024-01-10
    Topic
  • Fengyi LYU , Guangtao XIA
    doi: 10.13683/j.wph.2024.01.001

    Micro RNA (miR) is a class of endogenous non-coding small molecule RNA with a length of 20 -23 nucleotides, which is an important regulator of immune response. MiR-326 is involved in various pathophysiological processes in vivo, regulating various cell homeostasis and differentiation, including immune cells, and is closely related to multiple autoimmune disease (AID), which is expected to become a new therapeutic target. This article reviewed the relationship between miR-326 and AID and immune cells and the research progress, aiming to provide some reference for the research of new drugs.

  • Topic
  • Lei QIN , Fengyi LYU , Xiaoqing WANG
    doi: 10.13683/j.wph.2024.01.002

    B cell and humoral immunity play an important role in the occurrence and development of autoimmune disease (AID). B cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL) are necessary for the maintenance of B cell bank and humoral immunity. Telitacicept is a fusion protein of the Fc segment of APRIL and BAFF receptor transmembrane protein activator and immunoglobulin G, which can be used to treat AID. This article discussed the mechanism of action of telitacicept and its progress in the treatment of AID, including systemic lupus erythematosus, autoimmune nephropathy, neuromyelitis optica spectrum disorder and primary Sjogren's syndrome, in order to provide some reference for clinical use.

  • Article
  • Dan LI , Na LI , Ying LIANG , Xunting LI , Sujuan CAO
    doi: 10.13683/j.wph.2024.01.003
    Objective

    To investigate the effects of plasma exosomal micro RNA (miR)-21 on the growth and metastasis of diffuse large B-cell lymphoma (DLBCL) cells and its mechanism.

    Methods

    Extraction and identification of plasma exosomes from DLBCL patients. U2932 cells were divided into miR-21 mimic negative control (NC) group, miR-21 group, miR-21+phosphatase and tensin homolog deleted on chromosome ten (PTEN) group, phosphate buffer solution (PBS) group, DLBCL exosome group, DLBCL exosome+miR-21 inhibitor group (A group), DLBCL exosome+PTEN group (B group). Real time fluorescent quantitative polymerase chain reaction was used to detect miR-21 expression in U2932 cells. Dual luciferase was used to verify the targeting relationship between miR-21 and PTEN. The proliferation, migration and invasion ability of U2932 cells were detected by cell counting kit-8 and Transwell assay.

    Results

    The exosomes of DLBCL patients had a bilayer membranes with a "saucer-like" shape, with a particle size of 30~100 nm. The marker proteins tumor susceptibility gene 101, cluster of differentiation 9 and heat shock protein 70 were expressed on the surface. Dual luciferase reporter gene assay showed that PTEN was the target gene of miR-21. Compared with the miR-NC group, the proliferation, migration and invasion abilities of the U2932 cells in the miR-21 group were significantly increased (P<0.05). Compared with miR-21 group, the proliferation, migration and invasion ability of U2932 cells in miR-21+PTEN group were significantly decreased (P<0.05). Compared with PBS group, the expression of miR-21 in plasma exosome U2932 cells of DLBCL patients was significantly increased, and cell proliferation, migration and invasion were significantly enhanced (P<0.05). The proliferation, migration and invasion ability of U2932 cells in A and B groups were significantly lower than those in the plasma exosome group of DLBCL patients (P<0.05).

    Conclusion

    The plasma exosome miR-21 promotes the proliferation, migration and invasion of U2932 cells by inhibiting PTEN.

  • Article
  • Jing ZHAO , Jian ZHANG , Aimin HU , Yi TAO , Ling YAN
    doi: 10.13683/j.wph.2024.01.004
    Objective

    To investigate the protective effect of buyang huanwu decoction on diabetic peripheral neuropathy (DPN) through phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) autophagy pathway.

    Methods

    Forty-eight Wistar rats were grouped into control group (gavage+intravenous sterile saline solution of equal volume), DPN model group (gavage+intravenous sterile saline solution of equal volume), traditional Chinese medicine treatment group (gavage 2 g/kg buyang huanwu decoction) and PI3K inhibitor group (gavage 2 g/kg buyang huanwu decoction+intravenous 1.5 mg/kg PI3K inhibitor LY2940002). Except for the control group, DPN rats in the other three groups were given the corresponding drug treatment. The conduction index and the ultrastructure of the sciatic nerve were observed. Serum factor expression levels and neuronal autophagy and apoptosis was analyzed. Expression levels of relevant proteins were examined.

    Results

    Compared with the control group, the sciatic nerve myelin axons were severely lost in DPN model group, the myelin sheath was destroyed and curled, the organelles were reduced, the speed and amplitude of the sciatic nerve conduction action sites were decreased, the levels of autophagy and apoptosis were increased, and the levels of PI3K/Akt pathway was inhibited, and the differences were statistically significant (P<0.01). The above indexes were improved in the Chinese medicine treatment group, including ultrastructural changes, autophagy, apoptosis and PI3K/Akt pathway-related protein levels (P<0.01). However, PI3K inhibitor partially reversed the protective effect of buyang huanwu decoction on DPN rat model (P<0.01).

    Conclusion

    Buyang huanwu decoction may inhibit apoptosis and autophagy by activating the PI3K/Akt pathway, thereby exerting a protective effect on DPN rats.

  • Article
  • Bing YU , Meng ZHANG , Fei GUO , Huiting LI
    doi: 10.13683/j.wph.2024.01.005
    Objective

    To evaluate the efficacy and safety of nabuliumab combined with ipilimumab in the first-line treatment of locally advanced lung adenocarcinoma.

    Methods

    Ninety-two patients with locally advanced lung adenocarcinoma were randomly divided into control group and combined group by random number table method, 46 cases in each group. The control group received pemetrexed combined with cisplatin, and the combined group received nabuliumab combined with ipilimumab. Disease control rate (DCR), objective response rate (ORR), safety, tumor downstaging rate, major pathological response (MPR), pathological complete response (pCR) rate and tumor markers were compared between the two groups.

    Results

    The rates of ORR, DCR, tumor downstaging in the combined group were higher than those in the control group (P<0.05), and the incidence of adverse reaction in grade Ⅲ and above was lower than that in the control group (P<0.05). After 2 months of treatment, serum carcino-embryonic antigen (CEA), cytokeratin 19 fragment antigen 21-1 (Cyfra21-1) and neurone-specific enolase (NSE) levels in 2 groups were decreased compared with those before treatment (P<0.05), and serum CEA, Cyfra21-1 and NSE levels in combined group were significantly lower than those in control group (P<0.05).

    Conclusion

    Nabuliumab combined with ipilimumab in the first-line treatment of locally advanced lung adenocarcinoma can increase ORR, DCR, tumor descending stage rate, and the adverse reactions are controllable.

  • Article
  • Ruihong SONG , Liumei PU , Liwen LU
    doi: 10.13683/j.wph.2024.01.006
    Objective

    To explore the clinical effect of different inhaled drugs on patients with moderate or severe chronic obstructive pulmonary disease (COPD) in stable phase.

    Methods

    180 patients with moderate or severe stable COPD treated in our hospital from July 2020 to July 2022 were randomly divided into three groups: A group, B group and C group, and 60 cases in each group. The patients in A group were given tiotropium bromide, the patients in B group were given salmeterol/ticasone, and the patients in C group were treated with umeclidinium bromide/vilanterol trifenatate. Pulmonary function index, blood gas index, level of inflammatory factors and adverse events during intervention were compared before and after treatment among the three groups.

    Results

    After intervention, the clinical effective rate of A, B and C group increased successively, and the differences were statistically significant (P<0.05). The levels of forced expiratory volume in one second (FEV1), FEV1% pred and FEV1/forced vital capacity (FVC) in group C were significantly higher than those in A and B group (P<0.05), but there was no significant difference in the level of peak expiratory flow (PEF) among the three groups (P>0.05). The levels of PaO2 and SaO2 in group C were significantly higher than those in A and B group (P<0.05), while the level of PaCO2 in C group was significantly lower than that in A and B group (P<0.05). The levels of IL-6, IL-8 and TNF-α in C group were similar to those in B group (P>0.05) and significantly lower than those in A group (P<0.05). During the intervention period, the number of acute attacks in C group was significantly lower than that in A and B group (P<0.05), but there was no significant difference in adverse events among the three groups (P>0.05).

    Conclusion

    Umeclidinium bromide/vilanterol trifenatate can effectively improve pulmonary function and blood gas indexes, reduce inflammatory reaction, reduce the risk of acute attack in patients with moderate or severe stable COPD, with good safety.

  • Article
  • Zhuxin MAO , Lingxiang ZHUANG , Shitong XIE , Jing WU
    doi: 10.13683/j.wph.2024.01.007
    Objective

    To explore the treatment preferences of oral antidiabetic medications in Chinese type 2 diabetes patients.

    Methods

    Patients with type 2 diabetes were recruited and interviewed in three hospitals of different levels in Beijing. Semi-structured interviews were conducted to collect the factors that patients would consider when choosing oral antidiabetic medications. The interviews were recorded and transcribed into texts. Techniques of grounded theory were used to code important information from the texts. The extracted codes were summarized, classified and generated themes.

    Results

    A total of 27 patients were included in the study. Based on qualitative data analysis, five themes were summarized, namely, attention to efficacy, avoidance of medication risks, consideration of medication burden, consideration of medication costs, and the favor of reliable medication.

    Conclusions

    Patients with type 2 diabetes consider multiple aspects when evaluating and choosing oral antidiabetic medications. Healthcare services providers should focus on the medication preferences of people with type 2 diabetes to develop patient-centered treatment plans to achieve optimal adherence and clinical outcomes, and ultimately improve their health and well-being.

  • Article
  • Weiqi CHEN , Qiyun ZHU , Qinyi SUN , Zhao YANG , Bin JIANG
    doi: 10.13683/j.wph.2024.01.008
    Objective

    To compare the cost effectiveness of blinatumomab and chemotherapy in the treatment of relapsed or refractory precursor B-Cell acute lymphoblastic leukemia (ALL) from Chinese societal perspective.

    Methods

    A partition survival model with three health states (event-free, recurrence and death) was conducted over a 20 years horizon. Clinical data accessed from the phase Ⅲ randomized controlled clinical study 20120215, utility values were obtained from the quality of life study of leukemia patients in Shanghai Children's Medical Centre, and cost inputs were identified from the Eliancloud database, Menet database, National Bureau of Statistics etc. The threshold of willingness to pay (WTP) was CNY 128 547 (1.50 times of 2022 Chinese per capita GDP). Deterministic sensitivity analysis and probabilistic sensitivity analysis were conducted to access the robustness of model and findings.

    Results

    The patients of intervention group achieved 8.74 quality-adjusted life years (QALYs) and 10.53 life years (LYs), compared with control group, an increase of 3.01 QALYs and 3.46 LYs. The total cost for intervention group was CNY 1 060 929, an increase of CNY 245 719 compared with control group. The incremental cost effectiveness ratio (ICER) in intervention group compared with control group was CNY 81 623 per QALY. Results were robust to sensitivity analyses.

    Conclusion

    Blinatumomab is more cost effective in pediatric patients with relapsed or refractory precursor B-Cell ALL compared with chemotherapy from Chinese societal perspective.

  • Article
  • Manqi HU , Ziwen SUN , Jie CHEN , Ge YAN , Zhiya HUANG , Xiao MIAO
    doi: 10.13683/j.wph.2024.01.009
    Objective

    To observe the efficacy of compound Yinqiaojiedu mixture combined with acupuncture in treating moderate acne heat-toxin syndrome.

    Methods

    Patients with moderate acne heat-toxin syndrome were randomly divided into treatment group and control group, 30 cases in each group. The treatment group was treated with compound Yinqiaojiedu mixture (twice a day, 30 mL each time) combined with acupuncture clearance (once a week), and the control group was treated with minocycline hydrochloride (twice a day, 50 mg each time). The skin lesion count, traditional Chinese medicine (TCM) syndrome score, dermatology life quality index (DLQI) and inflammatory cytokines in peripheral blood, including interleukin (IL)-6, IL-1β and tumor necrosis factor (TNF)-α were compared between the two groups.

    Results

    The total effective rate was 90.00% in the treatment group and 93.33% in the control group, and there was no significant difference in the total effective rate between the two groups (P>0.05). The total effective rate of the two groups in the treatment of inflammatory skin lesions was 96.67%, and there was no significant difference between the two groups (P>0.05). The total effective rate of the treatment group in the treatment of non-inflammatory skin lesions was 86.67% and 76.67% in the control group, with no statistical significance between the two groups (P>0.05). The DLQI scores of both groups decreased significantly after treatment (P<0.05). The TCM syndrome score in the treatment group was lower than that in the control group after treatment (P<0.05). The levels of peripheral blood inflammatory cytokines in both groups were lower than those before treatment (P<0.05).

    Conclusion

    Compound Yinqiaojiedu mixture combined with acupuncture clearance is effective in the treatment of moderate acne heat-toxin syndrome with little adverse reaction, and it can improve the clinical syndrome of patients, which is worthy of clinical promotion and application.

  • Article
  • Jian SHEN , Jihu ZHAI , Jun WANG , Zhong LIU , Acheng ZHOU , Kun TANG
    doi: 10.13683/j.wph.2024.01.010
    Objective

    To explore the effect of Shengji Huayu recipe combined with hemorrhoid fistula lotion on postoperative wound healing and the expression of B-cell lymphoma (Bcl)-2 protein and Bcl-2 associated X protein (Bax) in wound granulation tissue after complicated anal fistula surgery.

    Methods

    A total of 80 patients with complex anal fistulas treated at our hospital were selected and randomly divided into the control group and the experimental group according to the random number table method, with 40 cases in each group. The control group received routine treatment with anal fistula cleansing solution, while the experimental group received Shengji Huayu recipe on the basis of the control group. The therapeutic effects were compared between the two groups.

    Results

    The total effective rate and wound healing rate of the experimental group were higher than those of the control group, and the scar area of the wound was smaller than that of the control group (P<0.05). After treatment, the symptom scores of pruritus, edema, exudation and pain in the two groups were mainly 1 point, and the score distribution in the experimental group was lower than that of the control group (P<0.05). After treatment, the levels of Actinobacteria, Proteobacteria and Bax in the experimental group were lower than those of the control group, and the levels of Bacteroides, Firmicutes and Bcl-2 were higher than those of the control group (P<0.05). No adverse reactions occurred in the two groups during treatment. During the follow-up of 6 months after discharge, the recurrence rate of the experimental group was lower than that of the control group (χ2=4.507, P=0.034).

    Conclusion

    Shengji Huayu recipe combined with Hemorrhoid Fistula Lotion has a significant effect in the application of elderly patients with complicated anal fistula surgery, which can effectively promote wound healing and symptom improvement, reduce wound scars and body inflammation, regulate the distribution of flora, and inhibit wound cell apoptosis. And it has high safety.

  • Article
  • Qingwei LI , Wei LI , Jidong YANG , Peng WU
    doi: 10.13683/j.wph.2024.01.011
    Objective

    To investigate the efficacy of sintilimab combined with sorafenib in the treatment of advanced liver cancer and its influence on serum alpha fetoprotein (AFP) and protein induced by vitamin K absence or antagonist Ⅱ (PIVKA-Ⅱ).

    Methods

    A total of 88 patients with advanced liver cancer treated in our hospital from April 2019 to June 2020 were selected and divided into control group and combined group according to random number table method. The control group given conventional treatment combined with sorafenib, and the combined group was given sintilimab on the basis of the control group, with 44 cases in each group. The disease control rates, liver function index, AFP and PIVKA-Ⅱlevels were compared between the two groups. The adverse reactions of patients and the median survival situation were observed.

    Results

    After treatment, the disease control rate of the combined group was higher than that of the control group (90.91% vs 72.73%, χ2=4.889, P=0.027). The levels of alanine aminotransferase, total bilirubin, AFP and PIVKA-Ⅱin both groups were lower than before treatment, and albumin was higher than before treatment, and the combined group was better than the control group, and the difference was statistically significant (P<0.05). The median survival time of the combined group was longer than that of the control group, and the difference was statistically significant (t=8.095, P<0.001). The 2-year survival rate in the combined group (17/44, 38.64%) was higher than that in the control group (8/44, 18.18%, χ2=5.320, P=0.021).

    Conclusion

    Sintilimab combined with sorafenib has good efficacy in the treatment of advanced liver cancer, can effectively improve the liver function of patients, and has a certain safety, worthy of clinical promotion and application.

  • Review
  • Ao ZHANG , Liping XIE
    doi: 10.13683/j.wph.2024.01.012

    Interleukin (IL)-4 is a multipotent cytokine that specifically binds to IL-4 receptor (IL-4R) on the cell surface to exert its biological effects. The expression level of IL-4R on the cell surface is relatively low under normal conditions and increases after being stimulated by hormones, stress and inflammation. At present, it has been found that IL-4/IL-4R plays an important role in the occurrence and development of atopic dermatitis, asthma, malignant tumor and other diseases. Currently, monoclonal antibody drugs targeting IL-4Rα have been used for clinical treatment, particularly for type 2 inflammation, and more than 8 therapeutic agents are in clinical research phase. This article reviewed the IL-4/IL-4R signaling pathway and related diseases, and the current status of research on therapeutic monoclonal antibody drugs targeting IL-4R and their clinical applications.

  • Review
  • Pei GAN , Xueke LIU , Xia LI
    doi: 10.13683/j.wph.2024.01.013

    Glaucoma is a group of neurodegenerative diseases with pathological increase of intraocular pressure (IOP) as the main risk factor. Local use of IOP-lowering drugs is still the first line of treatment. Most of the aqueous humor flows out through the trabecular meshwork (TM) pathway, which is the main site of primary open-angle glaucoma. Therefore, novel IOP lowering drugs targeting the TM pathway are very important for the treatment of glaucoma. This article reviewed the mechanism and progress of Rho kinase inhibitors, nitric oxide donors and other novel IOP lowering drugs in recent years, aiming to provide clinical reference.

  • Review
  • Chunqin ZENG , Qiang SHEN , Gaoming HU
    doi: 10.13683/j.wph.2024.01.014

    Retinal angiomatous proliferation (RAP) is a type of eye disease caused by angiogenesis. Microhemangioma is formed due to the imbalance of vascular growth factors and vascular inhibitory factors, which can seriously affect the visual acuity of patients. High expression of vascular endothelial growth factor (VEGF) can accelerate the development of RAP, and anti-VEGF can accelerate tumor atrophy and improve clinical efficacy. Currently, known anti-VEGF drugs include ranibizumab, bevacizumab and aflibercept, etc. In recent years, the role of anti-VEGF in RAP therapy has attracted much attention. This article reviewed the mechanism of VEGF in RAP and the progress of anti-VEGF therapy, aiming to provide clinical reference.

  • Review
  • Fanlingzi SHEN , Ruiping WANG
    doi: 10.13683/j.wph.2024.01.015

    Psoriasis is a common chronic, recurrent and inflammatory disease in dermatology, and the exact etiology of psoriasis has not been completely understood. Genetic and environmental factors are important factors that induce or aggravate psoriasis, among which tobacco smoking and alcohol drinking are common controllable risk factors. Studies have shown that the tobacco smoking rate of psoriasis patients is higher than that of general population. Tobacco smoking may affect the occurrence and the progress of psoriasis by enhancing the expression of psoriasis-related genes and activating psoriasis-related signaling pathways, thus increasing the risk of psoriasis and leading to the exacerbation of the condition of psoriasis patients. However, whether tobacco smoking affects the treatment effect of psoriasis patients remains controversial, and more clinical studies are needed to confirm the impact of tobacco smoking and cessation on the treatment effect of psoriasis patients. Epidemiological investigation shows that the alcohol drinking rate of psoriasis patients is higher than that of general population. Existing research evidence suggests that alcohol drinking may have adverse effects on the occurrence and the progress of psoriasis by affecting psoriasis-related susceptibility genes, affecting the proliferation and differentiation of keratinocytes and inducing abnormal activation of immune cells. At the same time, alcohol drinking may weaken the therapeutic response of psoriasis, making the treatment less effective. However, there is no unified conclusion on the relationship between alcohol drinking and the occurrence and severity of psoriasis. So more studies are needed to explore the association between alcohol drinking and psoriasis.

  • Pharmacy administration
  • Hongyu WANG , Jinxi DING , Wei LI
    doi: 10.13683/j.wph.2024.01.016
News